000 | 01483 a2200409 4500 | ||
---|---|---|---|
005 | 20250517131047.0 | ||
264 | 0 | _c20170710 | |
008 | 201707s 0 0 eng d | ||
022 | _a1522-1466 | ||
024 | 7 |
_a10.1152/ajprenal.00266.2016 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhong, Jianyong | |
245 | 0 | 0 |
_aA perspective on chronic kidney disease progression. _h[electronic resource] |
260 |
_bAmerican journal of physiology. Renal physiology _c03 2017 |
||
300 |
_aF375-F384 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAcute Kidney Injury _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aEpigenesis, Genetic |
650 | 0 | 4 | _aGenetic Markers |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aGlomerular Filtration Rate |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 |
_aKidney Failure, Chronic _xgenetics |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aProteinuria _xmetabolism |
650 | 0 | 4 |
_aRenal Insufficiency, Chronic _xdrug therapy |
650 | 0 | 4 | _aRenin-Angiotensin System |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aUrological Agents _xadverse effects |
700 | 1 | _aYang, Hai-Chun | |
700 | 1 | _aFogo, Agnes B | |
773 | 0 |
_tAmerican journal of physiology. Renal physiology _gvol. 312 _gno. 3 _gp. F375-F384 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajprenal.00266.2016 _zAvailable from publisher's website |
999 |
_c26697569 _d26697569 |